Clebopride

DB13511InvestigationalSmall molecule

Clebopride is a dopamine antagonist used to treat symptoms associated with functional gastrointestinal disorders. Clebopride may also be used to treat nausea and vomiting associated with chemotherapy.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 4 and Dopamine receptor D2
Curator reviewed
Formula / weight: C₂₀H₂₄ClN₃O₂ · 373.88 g/mol (avg)
Code names: LAS 9273

Resolves to

Compound

UNIII0A84520Y9CAS55905-53-8ChEMBLCHEMBL325109ChEBI92309

Clinical / RWD

RxNorm21224ATCA03FA06

Structure

InChIKeyBVPWJMCABCPUQY-UHFFFAOYSA-NSMILESCOC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CC2=CC=CC=C2)CC1

Targets

Q13639HTR4P14416DRD2P22303ACHE

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

26Drug interactionsStructured to mechanism, not free text

3Structured indicationsCondition, population, route and combination as fields, not prose

8ContraindicationsEach with its own population and attribute set

5Marketed productsAcross 2 countries and 3 labellers

1ATC codeIncluding every combination product, plus 13 drug categories

17+ReferencesStructured and connected to the statements they support

Which drugs share a target with Clebopride, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In